Found: 6
Select item for more details and to access through your institution.
Tislelizumab synergizes with surgery to augment the survival benefit in stage II-III non-small cell lung cancer.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01278-5
- By:
- Publication type:
- Article
H3K27ac‐activated LINC00519 promotes lung squamous cell carcinoma progression by targeting miR‐450b‐5p/miR‐515‐5p/YAP1 axis.
- Published in:
- Cell Proliferation, 2020, v. 53, n. 5, p. 1, doi. 10.1111/cpr.12797
- By:
- Publication type:
- Article
Non‑diagnostic electromagnetic navigation bronchoscopy biopsy: Predictive factors and final diagnoses.
- Published in:
- Oncology Letters, 2023, v. 25, n. 4, p. N.PAG, doi. 10.3892/ol.2023.13751
- By:
- Publication type:
- Article
The combination of a seven-autoantibody panel with computed tomography scanning can enhance the diagnostic efficiency of non-small cell lung cancer.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 01, doi. 10.3389/fonc.2022.1047019
- By:
- Publication type:
- Article
PD0166285 sensitizes esophageal squamous cell carcinoma to radiotherapy by dual inhibition of WEE1 and PKMYT1.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1061988
- By:
- Publication type:
- Article
Combination therapy of apatinib with icotinib for primary acquired icotinib resistance in patients with advanced pulmonary adenocarcinoma with EGFR mutation.
- Published in:
- Thoracic Cancer, 2018, v. 9, n. 5, p. 656, doi. 10.1111/1759-7714.12624
- By:
- Publication type:
- Article